GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Targeted Medical Pharma Inc (OTCPK:TRGM) » Definitions » Total Current Liabilities

Targeted Medical Pharma (Targeted Medical Pharma) Total Current Liabilities : $14.68 Mil (As of Dec. 2015)


View and export this data going back to 2012. Start your Free Trial

What is Targeted Medical Pharma Total Current Liabilities?

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Targeted Medical Pharma's total current liabilities for the quarter that ended in Dec. 2015 was $14.68


Targeted Medical Pharma Total Current Liabilities Historical Data

The historical data trend for Targeted Medical Pharma's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Targeted Medical Pharma Total Current Liabilities Chart

Targeted Medical Pharma Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Total Current Liabilities
Get a 7-Day Free Trial 7.48 12.25 11.26 12.35 14.68

Targeted Medical Pharma Quarterly Data
Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.35 13.33 13.22 13.97 14.68

Targeted Medical Pharma Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Targeted Medical Pharma's Total Current Liabilities for the fiscal year that ended in Dec. 2015 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=6.178+4.624
+Other Current Liabilities+Current Deferred Liabilities
=3.873+0
=14.68

Targeted Medical Pharma's Total Current Liabilities for the quarter that ended in Dec. 2015 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=6.178+4.624
+Other Current Liabilities+Current Deferred Liabilities
=3.873+0
=14.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.


Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term


Targeted Medical Pharma Total Current Liabilities Related Terms

Thank you for viewing the detailed overview of Targeted Medical Pharma's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Targeted Medical Pharma (Targeted Medical Pharma) Business Description

Traded in Other Exchanges
N/A
Address
2980 Beverly Glen Circle, Los Angeles, CA, USA, 90077
Targeted Medical Pharma Inc is a United States based specialty pharmaceutical company, which develops and commercializes amino acid-based medications. The business activities of the group are functioned through Targeted Medical Pharma; Complete Claims Processing, Inc. and Amino Nutritionals segments. The operations of the group are primarily functioned through the region of United States and it derives the majority of revenue from Targeted Medical Pharma segment which develops and distributes amino acid-based therapeutic products and distributes pharmaceutical products from other manufacturers through employed sales representatives, independent distributors, and pharmacies.
Executives
William B. Horne officer: Chief Financial Officer C/O AULT ALLIANCE, INC., 940 SOUTH COAST DRIVE, SUITE 200, COSTA MESA CA 92626
Maurice J Dewald director C/O TARGETED MEDICAL PHARMA, INC., 2980 BEVERLY GLEN CIRCLE, SUITE 100, LOS ANGELES CA 90077
Scott Gottlieb director MOLECULAR INSIGHT PHARMACEUTICALS, 160 SECOND STREET, CAMBRIDGE MA 02142
Ronald W Rudolph officer: See Remarks C/O TARGETED MEDICAL PHARMA, INC, 2980, BEVERLY GLEN CIRCLE, SUITE 301, LOS ANGELES CA 90077
Amir F Heshmatpour director, 10 percent owner, officer: Former President C/O AFH HOLDING & ADVISORY LLC, 9595 WILSHIRE BLVD, STE 900, BEVERLY HILLS CA 90212
John H Bluher director 12981 NORTH 2ND STREET, PARKER CO 80134
Steve B Warnecke officer: Chief Financial Officer C/O TARGETED MEDICAL PHARMA, INC., 2980 BEVERLY GLEN CIRCLE, SUITE 301, LOS ANGELES CA 90077
Afh Holding & Advisory, Llc 10 percent owner, other: Former 10% Owner 269 S. BEVERLY DRIVE, STE #1600, BEVERLY HILLS CA 90212
Timothy Brasel director, officer: Vice President 16178 EAST PRETENCE PLZ, AURORA CO 80015

Targeted Medical Pharma (Targeted Medical Pharma) Headlines

No Headlines